We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
The characteristics, diagnosis, management, surveillance and epidemiology of Pseudomonas aeruginosa.
The management, surveillance and epidemiology of carbapenem resistance.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Amoxycillin and Potassium Clavulanate Tablets seized at Heathrow Distribution Centre.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Check the tariff classification for components in sets for dental repair.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Information for patients who have been prescribed Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets COVID-19 antiviral medication.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
An overview of the process including submitting or fast tracking an application, naming your medicine and paying fees.
Competent authorities of exporting countries should use the relevant model health certificate as a template to create a version exporters can apply for to export other animal products to Great Britain, the Channel Islands or Isle of Man.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.